Deal type reports

Licensing Deals in Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2020 to 2026

Collaboration Deals in Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2021 to 2026

Distribution Deals in Medical Devices | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2026

Global coverage | Deal financials | Contract documents | Deal trends | Leading M&A dealmakers | Comprehensive deal directory 2021 to 2026

Collaboration Deals in Pharmaceuticals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2021 to 2026

Custom Executive Partnering Briefings apply Current Partnering’s proprietary pharma and biotech deal intelligence to your company, pipeline or strategic priorities. Each briefing delivers focused analysis of relevant deals, potential partners, financial benchmarks and market trends. Standalone briefings start from USD$3,995 with a free proposed table of contents and scope available on request.

Comprehensive analysis of royalty rates in pharmaceutical and biotechnology licensing agreements. Includes benchmarking of royalty structures, upfront payments, milestones, exclusivity provisions, territorial rights, development stages and financial terms from 1600+ disclosed licensing deals.